| Autor: |
Daniel Wills, Charlie Campion, Rema A. Oliver, William R. Walsh, Nathan Kucko, Florence de Groot |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
The Spine Journal. 21:S140 |
| ISSN: |
1529-9430 |
| DOI: |
10.1016/j.spinee.2021.05.209 |
| Popis: |
BACKGROUND CONTEXT Synthetic bone grafts are a promising alternative for the treatment of degenerative spine conditions and are available without the added drawbacks associated autografts including limited availability and donor-site morbidity. Of these synthetic materials, calcium phosphate (CaP) with a characteristic needle-shaped submicron surface topography (BCP PURPOSE This study was to evaluate the efficacy of a novel synthetic bone graft using a clinically-relevant “Boden” rabbit posterolateral spine fusion model. The synthetic bone graft comprised of CaP granules with a needle-shaped submicron surface structure (BCP STUDY DESIGN/SETTING The novel synthetic bone graft was first mixed in a 1:1 volume ratio with autologous bone (ABG). Subsequently, grafts were implanted in the rabbit posterolateral spine environment for 3 days, 6, 9 and 12 weeks. An autologous bone graft group was used as a positive control in this study. Outcomes for the test article were additionally compared to historical data for the same material (BCP OUTCOME MEASURES Spinal fusion was determined by manual palpation (MP), X-ray and µCT imaging (based on the Lenke scale), mechanical testing (range of motion testing at 12 weeks only) and histology (decalcified and undecalcified). METHODS Forty skeletally mature New Zealand white rabbits were divided into two groups and underwent single-level bilateral posterolateral intertransverse process spine arthrodesis at L4-5. Animals were euthanized after 3 days, 6, 9 and 12 weeks. RESULTS Based on all endpoints, the test group and positive control group showed an equivalent and gradual progression in bone formation and implant resorption over time, leading to mature fusion masses at 12 weeks. No adverse reactions were observed in any of the groups. Bilateral fusion rates by MP were consistent with the literature (0-40% at 6 weeks; 60-70% at 12 weeks) and similar trends were seen by histological and radiographic assessment (both X-ray and µCT). Flexion-extension and lateral bending results at 12 weeks demonstrated fusion of the treated level consistent with the MP results. The results observed for the test group were consistent with those seen historically for the same material implanted without the fibrillar collagen carrier. CONCLUSIONS These results show that BCP with needle-shaped submicron-scale surface topography (BCP FDA DEVICE/DRUG STATUS Col-BCP |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect